Endpoints News 生物医药· Anna Brown·· 2026-10-05AI 评分47
Sensible Bio完成4700万美元A轮融资用于mRNA治疗制造平台
Sensible Bio secures $47M Series A for mRNA therapy manufacturing platform
AI 导读
Sensible Biotech完成4700万美元A轮融资,用于支持其mRNA治疗制造平台。
正文
Sensible Biotechnologies is looking to mark its territory in the increasingly hot space of mRNA therapeutics, raising $47 million in a Series A round to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news